BBNX vs HCA · rev $100.3M vs P/E 17, rev $75.60B
Beta Bionics, Inc. Common Stock (BBNX) versus HCA Holdings Inc (HCA) — a side-by-side from cached financials, not a winner call.
Beta Bionics, Inc. Common Stock (BBNX) is a medical devices company listed on NASDAQ.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
Latest reported BBNX revenue for 2025-12-31 was $100.3M. Net income was -$73.2M. Revenue was up 53.9% from 2024-12-31 to 2025-12-31. BBNX currently screens at market cap $640.8M.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
BBNX currently screens at market cap $640.8M. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
Not investment advice. Open the BBNX and HCA stock pages for the full models.
Not investment advice.